Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹32Cr
Rev Gr TTM
Revenue Growth TTM
1,194.95%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

CAPRICORN
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 0.0 | -58.1 | -35.3 | -24.2 | -17.9 | 84.6 | 18.2 | 4.0 | 8.7 | 12.5 | 11.5 | 4,519.2 |
| 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 12 |
Operating Profit Operating ProfitCr |
| 7.1 | -61.5 | 9.1 | -36.0 | 0.0 | -175.0 | -161.5 | -19.2 | -4.0 | -37.0 | 3.5 | 0.3 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 0.0 | -900.0 | 200.0 | -325.0 | -100.0 | -425.0 | -2,200.0 | 44.4 | | 76.2 | 102.4 | 160.0 |
| 3.6 | -61.5 | 9.1 | -36.0 | 0.0 | -175.0 | -161.5 | -19.2 | -8.0 | -37.0 | 3.5 | 0.3 |
| 0.0 | -0.1 | 0.0 | -0.1 | 0.0 | -0.6 | -0.6 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -4.3 | 5.0 | 18.9 | -27.1 | 3.7 | -46.3 | -33.7 | 0.1 | -0.2 | -37.1 | 21.5 | 1,171.7 |
| 4 | 4 | 5 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 2 | 13 |
Operating Profit Operating ProfitCr |
| 6.2 | 5.1 | 3.1 | 2.3 | 0.3 | 3.0 | -32.5 | 4.6 | 4.6 | -19.0 | -89.8 | -0.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 42.0 | -12.6 | -42.3 | -58.0 | -130.8 | 505.2 | -1,691.8 | 111.0 | 12.1 | -372.4 | -518.7 | 91.2 |
| 2.6 | 2.2 | 1.1 | 0.6 | -0.2 | 1.4 | -33.1 | 3.6 | 4.1 | -17.7 | -90.3 | -0.6 |
| 0.3 | 0.1 | 0.1 | 0.1 | -1.9 | -0.1 | -0.6 | 0.1 | 0.1 | -0.2 | -1.3 | -0.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| 1 | 1 | 1 | 1 | 0 | 0 | -1 | 0 | 0 | 0 | -1 | -1 |
Current Liabilities Current LiabilitiesCr | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Non Current Assets Non Current AssetsCr | 5 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 285.8 | 15.7 | -77.4 | 2,460.4 | -9,708.4 | 385.2 | 6.5 | 708.9 | -242.4 | 191.9 | 3.6 |
CFO To EBITDA CFO To EBITDA% | 121.9 | 6.8 | -26.9 | 652.4 | 6,348.9 | 179.1 | 6.7 | 559.8 | -214.3 | 178.8 | 3.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 21 | 12 | 7 | 0 | 2 | 4 | 3 | 4 | 4 | 4 | 6 |
Price To Earnings Price To Earnings | 200.0 | 134.8 | 143.8 | 0.0 | 0.0 | 130.1 | 0.0 | 91.7 | 80.1 | 0.0 | 0.0 |
Price To Sales Price To Sales | 5.3 | 3.0 | 1.5 | 0.0 | 0.6 | 1.8 | 2.4 | 3.3 | 3.4 | 5.3 | 6.4 |
Price To Book Price To Book | 3.8 | 2.3 | 1.4 | 0.0 | 0.5 | 0.9 | 0.9 | 1.2 | 1.2 | 1.2 | 2.4 |
| 88.4 | 63.0 | 54.9 | 4.5 | 178.8 | 56.2 | -6.7 | 61.5 | 64.8 | -26.2 | -7.0 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| 6.2 | 5.1 | 3.1 | 2.3 | 0.3 | 3.0 | -32.5 | 4.6 | 4.6 | -19.0 | -89.8 |
| 2.6 | 2.2 | 1.1 | 0.6 | -0.2 | 1.4 | -33.1 | 3.6 | 4.1 | -17.7 | -90.3 |
| 2.5 | 2.1 | 1.2 | 2.8 | 1.6 | 1.3 | -12.4 | 2.0 | 1.9 | -4.1 | -32.9 |
| 1.9 | 1.7 | 1.0 | 0.4 | -0.2 | 0.7 | -12.5 | 1.3 | 1.4 | -4.0 | -33.0 |
| 1.5 | 1.3 | 0.8 | 0.3 | -0.2 | 0.6 | -11.5 | 1.1 | 1.3 | -3.9 | -27.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Capricorn Systems Global Solutions Limited is currently executing a high-stakes strategic transformation. Historically a niche provider of **Software Services** and **IT-enabled solutions** for the **United States** market, the company is pivoting toward a diversified model centered on **Large-scale Commodity Trading** and **Industrial Manufacturing**. This transition is being formalized through a major amalgamation with **Radical Bio-Organics Limited**, a move designed to scale the balance sheet and enter the high-margin distillery and bio-organics sector.
---
### **The Strategic Pivot: From Legacy IT to Industrial Diversification**
The company is moving away from its low-capital, project-based IT roots toward a capital-intensive, high-volume trading and manufacturing framework.
* **Amalgamation with Radical Bio-Organics Limited:** This is the cornerstone of the company’s future. The merger integrates a high-turnover manufacturing entity into the listed Capricorn entity.
* **New Business Verticals:** In **September 2025**, the company formally amended its Object Clause to authorize the trading, supply, and distribution of:
* **Agricultural Commodities:** Rice (broken/whole), wheat, pulses, oilseeds, and food grains.
* **Industrial Commodities:** Coal, granite, husk, and minerals.
* **Chemicals & Oils:** Edible/non-edible oils (palm, soybean, sunflower) and food additives.
* **Manufacturing Entry:** Post-merger, the company will produce **Extra Neutral Alcohol (ENA)**, **Impure Spirit (IS)**, **Dried Distiller Grain with Soluble (DDGS)**, and **Solid Carbon Dioxide ($\text{CO}_2$)**.
---
### **Comparative Scale: Transferee vs. Transferor**
The following table illustrates the significant scale-up the company will undergo upon the completion of the merger (data as of **February 2026**):
| Particulars | Capricorn Systems (Transferee) | Radical Bio-Organics (Transferor) |
| :--- | :--- | :--- |
| **Turnover** | **Rs. 20.74 Crore** | **Rs. 451.86 Crore** |
| **Total Assets** | **Rs. 28.78 Crore** | **Rs. 225.87 Crore** |
| **Net Worth** | **Rs. 26.33 Crore** | **Rs. 71.80 Crore** |
| **Share Exchange Ratio** | **1:1** | (1 share of Capricorn for 1 of Radical) |
---
### **Operational Framework & Logistics Model**
To manage the transition into physical commodities without excessive overhead, the company has adopted a lean operational strategy:
* **"Bill-to-Ship" Model:** Trading operations utilize a direct dispatch system from the point of procurement to the purchaser, minimizing capital-intensive inventory requirements.
* **Strategic Warehousing:** While the "bill-to-ship" model is preferred, the company maintains owned or leased warehouses (including pre-fabricated buildings) specifically for **Rice** inventory to manage moisture content and the essential maturing process.
* **Indigenous Technology:** The legacy IT segment operates on **100% indigenous technology** with **zero technology imports** over the last **five years**.
* **R&D Focus:** An in-house team focuses on the **upgradation and development** of existing tech products to support automated production and real-time market data analysis for the new trading arms.
---
### **Capital Raising & Financial Restructuring**
The company has aggressively expanded its capital base to fund the working capital requirements of its new high-volume trading business.
* **Rights Issue (Feb 2025):** Allotted **2,39,76,000** shares at **₹10** per share (Ratio **6:1**), raising gross proceeds of **₹2,397.60 lakhs**.
* **Preferential Warrants (Apr 2025):** Issued **1,70,00,000** warrants at **₹14.71** per warrant, totaling **₹20.01 Crore** for capital expenditure.
* **Authorized Capital Expansion:** Increased from **₹5 Crore** to **₹32 Crore** by **August 2025**.
* **Investment Limits:** Approved Section 186 limits up to **₹500 Crore** for future loans and investments.
**Projected Working Capital Allocation (FY 2025-26):**
| Component | Projected Amount (₹ in Lakhs) |
| :--- | :--- |
| **Inventory** | **750.00** |
| **Advances to Suppliers** | **850.00** |
| **Trade Receivables** | **600.00** |
| **Total Working Capital Requirement** | **1,800.00** |
---
### **Historical Financial Performance & Liquidity**
The company’s financials reflect the "growing pains" of a major pivot, characterized by rising operational costs and a temporary dip in profitability.
| Metric (₹ in Lakhs) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **100.81** | **82.97** | - |
| **Net Profit / (Loss)** | **(91.11)** | **(15.10)** | - |
| **Net Worth** | **276.00** | **367.00** | - |
| **Debt/Institutional Finance** | **Nil** | **Nil** | **Nil** |
* **Revenue Volatility:** A **37.10% decline** in FY 2024 was followed by a **21.50% recovery** in FY 2025.
* **Working Capital Deficit:** As of March 2025, the legacy business reported **negative net working capital of (321.16)**, which the recent Rights Issue is intended to rectify.
* **Zero Debt:** Historically, the company has operated with **zero bank or institutional finance**, relying entirely on own funds and equity raises.
---
### **Risk Matrix & Mitigation Factors**
Investors should consider the following risks associated with the company’s new direction:
* **Commodity Price & Inventory Risk:** Vulnerability to fluctuations between **paddy procurement** and the sale of **aged rice**. Sub-optimal storage can lead to moisture damage and product rejection.
* **Revenue Concentration:** A significant portion of legacy IT revenue is derived from a **single foreign client**, making the company sensitive to that client's stability.
* **Foreign Exchange Exposure:** Significant exposure to **Rupee-USD fluctuations** impacts export revenues; the company currently lacks a robust hedging mechanism.
* **Promoter Dilution:** Promoters have indicated they will **not subscribe** to their **Rights Entitlements**, which will lead to a dilution of their shareholding and voting power.
* **Regulatory Hurdles:** The company is navigating the financial impact of **New Labour Codes** (notified Nov 2025), which have already increased **employee benefit expenses**.
---
### **Future Outlook & Growth Targets**
Management’s primary objective is a **re-rating of shares** through increased scale and improved financial visibility.
* **Revenue Target:** The company projects a turnover of **₹60 Crore** from the commodities trading vertical alone for **FY 2025-26**.
* **Operational Synergies:** The merger is expected to yield cost efficiencies through **bulk procurement** and the rationalization of shared functions (Finance, HR, and IT).
* **Market Positioning:** By combining Radical Bio-Organics' manufacturing with Capricorn’s trading expertise, the entity aims to attract a broader **institutional investor base** and improve **share liquidity**.